U.S. Markets open in 7 hrs 19 mins

Top Picks 2020- Horizon Therapeutics HZNP and Qorvo QRVO

·2 min read

Jeffrey Hirsch — editor of Stock Trader's Almanac — select Global Brass and Copper Holdings as his favorite small cap stock for 2019. Following an April merger announcement, Global Brass shareholders received $44 per share in cash for a gain of roughly 75%. This year, Hirsch offers two risk-oriented ideas.

Horizon Therapeutics (HZNP) was part of our October “Best Months” Stock Basket and was added to our newsletter portfolio on October 18 at $27.94. Horizon develops therapies for rare and rheumatic diseases.

See also:: Top Picks 2020: National Fuel Gas (NFG)

HZNP has rallied recently following a positive recommendation for its experimental eye drug from a Food and Drug Administration advisory committee. The committee voted 12-0 in favor of the FDA approving teprotumumab as a treatment for thyroid eye disease (TED), a rare autoimmune disorder.

Qorvo (QRVO) was also part of our October “Best Months” Stock Basket and was added to our newsletter portfolio on October 18 at $77.89. QRVO is a leader in the 5G space, which promises to be the place for innovation in the near future.

QRVO is the best performing position from our October Stock Basket thus far due to strong earnings and guidance. QRVO gave credit to an upswing in smartphone manufacturing and the 5G build out. The company produces some of the best quality radio frequency solutions necessary for 5G deployment.

Both stocks came through our fundamental screens back in mid-October exhibiting accelerating revenue and earnings growth with attractive valuations, flying below Wall Street’s radar.

See also: Top Picks 2020: Nektar Therapeutics (NKTR)

Both stocks are up dramatically since our October 2019 recommendations, but these moves appear to be just the beginning of much larger moves based on HZNP’s developmental pipeline and QRVO’s place as one of the best positioned stocks to cash in on the 5G led semiconductor resurgence.

More From MoneyShow.com: